These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 749547)

  • 1. Clinical dextrans. Specifications and quality of preparations on the market.
    Nilsson K; Söderlund G
    Acta Pharm Suec; 1978; 15(6):439-54. PubMed ID: 749547
    [No Abstract]   [Full Text] [Related]  

  • 2. [Calibration of gel-chromatographic columns for examination of dextrans for clinical use].
    Araco A; Frontali C
    Ann Ist Super Sanita; 1976; 12(4):289-94. PubMed ID: 1030603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measurement and control of quality determining properties of clinical dextrans.
    Nilsson K
    Dev Biol Stand; 1980; 48():169-77. PubMed ID: 6168502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Characterization of clinical dextrans].
    Appel W
    Med Klin; 1971 Mar; 66(13):484-9. PubMed ID: 5558445
    [No Abstract]   [Full Text] [Related]  

  • 5. [Urinary excretion of dextran preparations of various molecular weights, with special reference to the molecular weight distribution and excretion of Plasmodex].
    Simon S
    Acta Pharm Hung; 1967 Jul; 37(4):178-85. PubMed ID: 5601700
    [No Abstract]   [Full Text] [Related]  

  • 6. WHO Expert Committee on Specifications for Pharmaceutical Preparations. Twenty-fourth report.
    World Health Organ Tech Rep Ser; 1972; 487():1-86. PubMed ID: 4623961
    [No Abstract]   [Full Text] [Related]  

  • 7. WHO Expert Committee on Specifications for Pharmaceutical Preparations.
    World Health Organ Tech Rep Ser; 2008; (948):1-138. PubMed ID: 18557474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. WHO Expert Committee on Specifications for Pharmaceutical Preparations.
    World Health Organization
    World Health Organ Tech Rep Ser; 2014; (986):1-387, back cover. PubMed ID: 24964711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. WHO Expert Committee on Specifications for Pharmaceutical Preparations. Fiftieth report.
    World Health Organ Tech Rep Ser; 2016; (996):1-358, back cover. PubMed ID: 27514184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. WHO Expert Committee on Specifications for Pharmaceutical Preparations. Forty-first report.
    World Health Organization
    World Health Organ Tech Rep Ser; 2007; (943):1-156. PubMed ID: 17621973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. WHO Expert Committee on Specifications for Pharmaceutical Preparations.
    World Health Organization
    World Health Organ Tech Rep Ser; 2011; (961):1-428, back cover. PubMed ID: 21699061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacopoeia as quality codex for the manufacturers.
    Soldi A
    Ann Ist Super Sanita; 1975; 11(3-4):269-80. PubMed ID: 1234728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role and functions of the International Pharmacopoeia.
    Wieniawski W
    Ann Ist Super Sanita; 1975; 11(3-4):204-10. PubMed ID: 1234722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statistical considerations in setting product specifications.
    Dong X; Tsong Y; Shen M
    J Biopharm Stat; 2015; 25(2):280-94. PubMed ID: 25358110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Control systems engineering in continuous pharmaceutical manufacturing. May 20-21, 2014 Continuous Manufacturing Symposium.
    Myerson AS; Krumme M; Nasr M; Thomas H; Braatz RD
    J Pharm Sci; 2015 Mar; 104(3):832-9. PubMed ID: 25546650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Criteria of purity and specifications, an essential premise to the beginning of any toxicological investigation].
    Gatti GL
    Ann Ist Super Sanita; 1982; 18(4):641-2. PubMed ID: 7188520
    [No Abstract]   [Full Text] [Related]  

  • 17. [Current domestically produced dextran preparations and certain new dextran derivatives].
    Mioduszewski JZ
    Pol Tyg Lek; 1969 Jul; 24(27):1048-50. PubMed ID: 5805883
    [No Abstract]   [Full Text] [Related]  

  • 18. [Preparation and quality control of low molecular weight chitosan].
    Huang X; Hu FQ; Yuan H; Ying XY
    Zhongguo Zhong Yao Za Zhi; 2005 Jul; 30(14):1076-9. PubMed ID: 16161441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Uniformity of unit-dose pharmaceutical preparations. Tests for the specifications of the uniformity of the pharmacopoeias, evaluation of the permitted variability, transfer of specifications to the control of production, variability found in the Italian pharmaceutical production, proposals for future specifications of uniformity].
    Cavatorta L; Cingolani E; Fontani F; Mecarelli E; Melandri MM; Pietra E; Pietra V; Rocchi B
    Boll Chim Farm; 1973 Apr; 112(4):226-45. PubMed ID: 4721646
    [No Abstract]   [Full Text] [Related]  

  • 20. WHO Expert Committee on Specifications for Pharmaceutical Preparations.
    World Health Organ Tech Rep Ser; 2003; 917():i-viii, 1-125, back cover. PubMed ID: 15024913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.